ES2054333T3 - Forma de dosificacion para administrar un antagonista del calcio. - Google Patents

Forma de dosificacion para administrar un antagonista del calcio.

Info

Publication number
ES2054333T3
ES2054333T3 ES90901388T ES90901388T ES2054333T3 ES 2054333 T3 ES2054333 T3 ES 2054333T3 ES 90901388 T ES90901388 T ES 90901388T ES 90901388 T ES90901388 T ES 90901388T ES 2054333 T3 ES2054333 T3 ES 2054333T3
Authority
ES
Spain
Prior art keywords
administer
dosage form
calcium antagonist
nicardipine
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90901388T
Other languages
English (en)
Inventor
Joseph C Deters
David R Swanson
Rosa Stephen C De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2054333T3 publication Critical patent/ES2054333T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PRESENTA UNA FORMA DE DOSIFICACION (10) QUE CONSTA DE UN MIEMBRO SELECCIONADO DEL GRUPO QUE CONSISTE EN NICARDIPINA Y SUS SALES FARMACEUTICAMENTE ACEPTABLES PARA ADMINISTRARLOS A UN PACIENTE QUE NECESITA UNA TERAPIA CARDIOVASCULAR.
ES90901388T 1989-01-30 1989-12-18 Forma de dosificacion para administrar un antagonista del calcio. Expired - Lifetime ES2054333T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30370689A 1989-01-30 1989-01-30

Publications (1)

Publication Number Publication Date
ES2054333T3 true ES2054333T3 (es) 1994-08-01

Family

ID=23173326

Family Applications (2)

Application Number Title Priority Date Filing Date
ES90901388T Expired - Lifetime ES2054333T3 (es) 1989-01-30 1989-12-18 Forma de dosificacion para administrar un antagonista del calcio.
ES9000257A Expired - Fee Related ES2026304A6 (es) 1989-01-30 1990-01-29 Procedimiento de fabricacion de una forma de dosificacion de nicardipina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES9000257A Expired - Fee Related ES2026304A6 (es) 1989-01-30 1990-01-29 Procedimiento de fabricacion de una forma de dosificacion de nicardipina.

Country Status (11)

Country Link
EP (1) EP0455648B1 (es)
JP (1) JPH04503058A (es)
AU (1) AU621182B2 (es)
CA (1) CA2007106A1 (es)
DK (1) DK23790A (es)
ES (2) ES2054333T3 (es)
FI (1) FI913608A0 (es)
GR (1) GR1000419B (es)
IE (1) IE61872B1 (es)
PT (1) PT92994B (es)
WO (1) WO1990008536A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
WO1999029297A1 (en) * 1997-12-05 1999-06-17 Alza Corporation Osmotic dosage form comprising first and second coats
DK1067910T3 (da) 1998-04-03 2004-10-04 Egalet As Komposition med styret afgivelse
EP1429739A1 (en) 2001-09-21 2004-06-23 Egalet A/S Polymer release system
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
WO2004041252A1 (en) 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
DE602004031096D1 (de) 2003-03-26 2011-03-03 Egalet As Morphin-system mit kontrollierter freisetzung
WO2004084869A1 (en) 2003-03-26 2004-10-07 Egalet A/S Matrix compositions for controlled delivery of drug substances
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device
DE602006003639D1 (de) * 2005-01-27 2008-12-24 Alza Corp Orale osmotische darreichungsform mit membran mit hoher flussdichte
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
US9005660B2 (en) 2009-02-06 2015-04-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
CA2766179A1 (en) 2009-06-24 2010-12-29 Egalet Ltd. Controlled release formulations
JP2015521988A (ja) 2012-07-06 2015-08-03 イガレット・リミテッド 制御放出用乱用防止性医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form

Also Published As

Publication number Publication date
PT92994A (pt) 1990-07-31
CA2007106A1 (en) 1990-07-30
AU621182B2 (en) 1992-03-05
DK23790A (da) 1990-07-31
JPH04503058A (ja) 1992-06-04
AU4811490A (en) 1990-08-24
EP0455648B1 (en) 1993-03-10
PT92994B (pt) 1995-12-29
IE61872B1 (en) 1994-11-30
GR900100015A (en) 1991-06-07
IE900296L (en) 1990-07-30
EP0455648A1 (en) 1991-11-13
FI913608A0 (fi) 1991-07-29
DK23790D0 (da) 1990-01-29
ES2026304A6 (es) 1992-04-16
WO1990008536A1 (en) 1990-08-09
GR1000419B (el) 1992-06-30

Similar Documents

Publication Publication Date Title
ES2054333T3 (es) Forma de dosificacion para administrar un antagonista del calcio.
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
AR008878A1 (es) Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento.
FI925342A (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
NO920946L (no) Oral antikoagulant/blodplateinhibitor i lavdoseformulering
NO306377B1 (no) Doseform for avgivelse av et medikament
DE68909772T2 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
DE60143911D1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
ES2034035T3 (es) Procedimiento de preparacion de una forma farmaceutica para la administracion y/o dosificacion de medicamentos.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
ES2188663T3 (es) Uso de productos que contienen magnesio para el tratamiento o profilaxis de enfermedades neoplasicas o autoinmunes.
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
ES2094834T3 (es) Dispositivo para el lavado, para finalidades terapeuticas o de higiene, de conductos internos humanos o animales.
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
AR023452A1 (es) Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor
ES2043736T3 (es) Acidos 3,5-dihidroxi-heptanoicos sustituidos con (1h-pirrol-3-ilo) en posicion 7, sus correspondientes delta-lactonas y sales, procedimientos para su preparacion, su utilizacion como medicamentos, preparados farmaceuticos y productos intermedios.
DK400887D0 (da) Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel
MX9203735A (es) Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 455648

Country of ref document: ES